Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of Sarpogrelate SR in Patients With Chronic Artery Occlusive Disease [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the efficacy and safety of Sarpogrelate SR in chronic arterial occlusive disease and intermittent claudication has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arterial Occlusive Disease
• Intermittent Claudication

Drugs mentioned

• Sarpogrelate SR (sarpogrelate sustained release)

Snippet

Sponsor: Yuhan Corporation | Conditions: Arterial Occlusive Diseases, Intermittent Claudication | Phase 4 | Status: COMPLETED